Difference between revisions of "Palantir will soon help the FDA evaluate drugs, including COVID-19 treatments (Q5073)"
Jump to navigation
Jump to search
(Created claim: concerns (P110): health data (Q2990)) |
(Created claim: official website (P15): https://techcrunch.com/2020/12/08/palantirs-fda-hhs-contract/) |
||||||||||||||
| (One intermediate revision by the same user not shown) | |||||||||||||||
| Property / date | |||||||||||||||
| + | 8 December 2020
| ||||||||||||||
| Property / date: 8 December 2020 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / official website | |||||||||||||||
| + | |||||||||||||||
| Property / official website: https://techcrunch.com/2020/12/08/palantirs-fda-hhs-contract/ / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
Latest revision as of 17:06, 17 December 2020
No description defined
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Palantir will soon help the FDA evaluate drugs, including COVID-19 treatments
|
No description defined
|
Statements
8 December 2020
0 references